BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33796119)

  • 1. Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques.
    Pedreño-Lopez N; Rosen BC; Flores WJ; Gorman MJ; Voigt TB; Ricciardi MJ; Crosno K; Weisgrau KL; Parks CL; Lifson JD; Alter G; Rakasz EG; Magnani DM; Martins MA; Watkins DI
    Front Immunol; 2021; 12():657424. PubMed ID: 33796119
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
    Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
    Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
    J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.
    Martins MA; Shin YC; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Castro I; Magnani DM; Ricciardi M; Pedreño-Lopez N; Bailey V; Betancourt D; Altman JD; Pauthner M; Burton DR; von Bredow B; Evans DT; Yuan M; Parks CL; Ejima K; Allison DB; Rakasz E; Barber GN; Capuano S; Lifson JD; Desrosiers RC; Watkins DI
    PLoS Pathog; 2017 Jul; 13(7):e1006529. PubMed ID: 28732035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.
    Nakane T; Nomura T; Shi S; Nakamura M; Naruse TK; Kimura A; Matano T; Yamamoto H
    PLoS One; 2013; 8(9):e73453. PubMed ID: 24039947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.
    von Gegerfelt A; Valentin A; Alicea C; Van Rompay KK; Marthas ML; Montefiori DC; Pavlakis GN; Felber BK
    J Immunol; 2010 Sep; 185(6):3348-58. PubMed ID: 20702730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
    Binley JM; Clas B; Gettie A; Vesanen M; Montefiori DC; Sawyer L; Booth J; Lewis M; Marx PA; Bonhoeffer S; Moore JP
    Virology; 2000 Apr; 270(1):237-49. PubMed ID: 10772996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
    Pahar B; Kenway-Lynch CS; Marx P; Srivastav SK; LaBranche C; Montefiori DC; Das A
    Virol J; 2016 Dec; 13(1):200. PubMed ID: 27903274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge.
    Patel V; Jalah R; Kulkarni V; Valentin A; Rosati M; Alicea C; von Gegerfelt A; Huang W; Guan Y; Keele BF; Bess JW; Piatak M; Lifson JD; Williams WT; Shen X; Tomaras GD; Amara RR; Robinson HL; Johnson W; Broderick KE; Sardesai NY; Venzon DJ; Hirsch VM; Felber BK; Pavlakis GN
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2975-80. PubMed ID: 23359688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
    Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
    J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
    Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
    J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.
    Jaworski JP; Kobie J; Brower Z; Malherbe DC; Landucci G; Sutton WF; Guo B; Reed JS; Leon EJ; Engelmann F; Zheng B; Legasse A; Park B; Dickerson M; Lewis AD; Colgin LM; Axthelm M; Messaoudi I; Sacha JB; Burton DR; Forthal DN; Hessell AJ; Haigwood NL
    J Virol; 2013 Oct; 87(19):10447-59. PubMed ID: 23885083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.